These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1851783)

  • 21. Effects of endothelin on resistance arteries of DOCA-salt hypertensive rats.
    Deng LY; Schiffrin EL
    Am J Physiol; 1992 Jun; 262(6 Pt 2):H1782-7. PubMed ID: 1621836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The 5-hydroxytryptamine2B receptor and 5-HT receptor signal transduction in mesenteric arteries from deoxycorticosterone acetate-salt hypertensive rats.
    Watts SW; Baez M; Webb RC
    J Pharmacol Exp Ther; 1996 May; 277(2):1103-13. PubMed ID: 8627522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular changes in DOCA hypertension. Influence of a low protein diet.
    Moreland RS; Webb RC; Bohr DF
    Hypertension; 1982; 4(5 Pt 2):III99-107. PubMed ID: 7106953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coronary vascular reactivity is improved by endothelin A receptor blockade in DOCA-salt hypertensive rats.
    Giulumian AD; Pollock DM; Clarke N; Fuchs LC
    Am J Physiol; 1998 Jun; 274(6):R1613-8. PubMed ID: 9608015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of potassium channels by tempol in arterial smooth muscle cells from normotensive and deoxycorticosterone acetate-salt hypertensive rats.
    Xu H; Jackson WF; Fink GD; Galligan JJ
    Hypertension; 2006 Dec; 48(6):1080-7. PubMed ID: 17060504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurotransmitter release, vascular responsiveness and their suppression by Ca-antagonist in perfused mesenteric vasculature of DOCA-salt hypertensive rats.
    Tsuda K; Kuchii M; Nishio I; Masuyama Y
    Clin Exp Hypertens A; 1986; 8(2):259-75. PubMed ID: 3720003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential contribution of endothelial function to vascular reactivity in conduit and resistance arteries from deoxycorticosterone-salt hypertensive rats.
    White RM; Rivera CO; Davison CB
    Hypertension; 1996 Jun; 27(6):1245-53. PubMed ID: 8641731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebral intraventricular 6-hydroxydopamine prevents vascular changes in the mineralocorticoid hypertensive rat.
    Mecca TE; Lamb FS; Hall JL; Webb RC
    Proc Soc Exp Biol Med; 1985 Jun; 179(2):248-53. PubMed ID: 3921975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebral vascular responsiveness in deoxycorticosterone acetate-salt hypertensive rats.
    Soltis EE; Bohr DF
    Am J Physiol; 1987 Jan; 252(1 Pt 2):H198-203. PubMed ID: 3812710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcium, phosphoinositide, and 1,2-diacylglycerol responses of blood vessels of deoxycorticosterone acetate-salt hypertensive rats to endothelin-1.
    Flückiger JP; Nguyen PV; Li G; Yang XP; Schiffrin EL
    Hypertension; 1992 Jun; 19(6 Pt 2):743-8. PubMed ID: 1317355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced release of endothelium-derived relaxing factor in mineralocorticoid hypertension.
    Bockman CS; Jeffries WB; Pettinger WA; Abel PW
    Hypertension; 1992 Sep; 20(3):304-13. PubMed ID: 1516949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphoinositide 3-kinase mediates enhanced spontaneous and agonist-induced contraction in aorta of deoxycorticosterone acetate-salt hypertensive rats.
    Northcott CA; Poy MN; Najjar SM; Watts SW
    Circ Res; 2002 Aug; 91(4):360-9. PubMed ID: 12193470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotonin-induced contraction in mesenteric resistance arteries: signaling and changes in deoxycorticosterone acetate-salt hypertension.
    Watts SW
    Hypertension; 2002 Mar; 39(3):825-9. PubMed ID: 11897772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential alterations in sympathetic neurotransmission in mesenteric arteries and veins in DOCA-salt hypertensive rats.
    Luo M; Hess MC; Fink GD; Olson LK; Rogers J; Kreulen DL; Dai X; Galligan JJ
    Auton Neurosci; 2003 Feb; 104(1):47-57. PubMed ID: 12559203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidermal growth factor: a potent vasoconstrictor in experimental hypertension.
    Florian JA; Watts SW
    Am J Physiol; 1999 Mar; 276(3):H976-83. PubMed ID: 10070082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lanthanum potentiation of the vascular response to a protein kinase C activator in genetically hypertensive rats.
    Raval J; Joshua IG; Webb RC; Bohr DF
    J Hypertens Suppl; 1989 Dec; 7(6):S146-7. PubMed ID: 2632698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Greater calmodulin-dependent regulation of neurotransmitter release and vascular responsiveness in chronic Doca-salt hypertension.
    Tsuda K; Tsuda S; Goldstein M; Masuyama Y
    Am J Hypertens; 1989 Feb; 2(2 Pt 1):93-8. PubMed ID: 2537092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of endothelium on Mg(2+)-induced relaxation in noradrenaline-contracted aorta from DOCA-salt hypertensive rat.
    Laurant P; Berthelot A
    Eur J Pharmacol; 1994 Jun; 258(3):167-72. PubMed ID: 8088352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phorbol ester-induced contraction through p38 mitogen-activated protein kinase is diminished in aortas from DOCA-salt hypertensive rats.
    Lee CK; Kim J; Won KJ; Lee HM; Kim HJ; Roh HY; Park HJ; Shin HS; Park TK; Kim B; Lee SM
    Arch Pharm Res; 2006 Nov; 29(11):1024-31. PubMed ID: 17146972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coronary artery reactivity in deoxycorticosterone acetate hypertensive rats.
    Hagen EC; Webb RC
    Am J Physiol; 1984 Sep; 247(3 Pt 2):H409-14. PubMed ID: 6383078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.